Business Description
CARsgen Therapeutics Holdings Ltd
ISIN : KYG1996C1006
Share Class Description:
HKSE:02171: Ordinary SharesCompare
Compare
Traded in other countries / regions
02171.Hong KongCRTHF.USA IPO Date
2021-06-18Description
CARsgen Therapeutics Holdings Ltd is a clinical-stage biopharmaceutical company discovering, researching, and developing cell therapies in the People's Republic of China and the United States of America.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.76 | |||||
| Equity-to-Asset | 0.71 | |||||
| Debt-to-Equity | 0.14 | |||||
| Debt-to-EBITDA | -0.32 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 15.3 | |||||
| 3-Year EPS without NRI Growth Rate | -27.3 | |||||
| 3-Year FCF Growth Rate | -11.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 26.42 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.67 | |||||
| 9-Day RSI | 54.1 | |||||
| 14-Day RSI | 56.83 | |||||
| 6-1 Month Momentum % | -38.68 | |||||
| 12-1 Month Momentum % | -63.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.47 | |||||
| Quick Ratio | 9.44 | |||||
| Cash Ratio | 9 | |||||
| Days Inventory | 222.63 | |||||
| Days Sales Outstanding | 199.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.6 | |||||
| Shareholder Yield % | 1.87 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 25.51 | |||||
| Operating Margin % | -11744.13 | |||||
| Net Margin % | -11047.4 | |||||
| FCF Margin % | -9153.82 | |||||
| ROE % | -37.73 | |||||
| ROA % | -29.66 | |||||
| ROIC % | -125.5 | |||||
| ROC (Joel Greenblatt) % | -186.26 | |||||
| ROCE % | -32.79 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 554.2 | |||||
| PB Ratio | 2.26 | |||||
| Price-to-Tangible-Book | 2.28 | |||||
| EV-to-EBIT | -2.98 | |||||
| EV-to-EBITDA | -3.11 | |||||
| EV-to-Revenue | 326.96 | |||||
| EV-to-FCF | -2.88 | |||||
| Price-to-Net-Current-Asset-Value | 2.98 | |||||
| Price-to-Net-Cash | 3.24 | |||||
| Earnings Yield (Greenblatt) % | -33.56 | |||||
| FCF Yield % | -17.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
CARsgen Therapeutics Holdings Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 6.825 | ||
| EPS (TTM) (HK$) | -1.345 | ||
| Beta | 1.23 | ||
| Volatility % | 111.6 | ||
| 14-Day RSI | 56.83 | ||
| 14-Day ATR (HK$) | 0.809894 | ||
| 20-Day SMA (HK$) | 6.5985 | ||
| 12-1 Month Momentum % | -63.36 | ||
| 52-Week Range (HK$) | 2.48 - 9.78 | ||
| Shares Outstanding (Mil) | 548.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CARsgen Therapeutics Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CARsgen Therapeutics Holdings Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
CARsgen Therapeutics Holdings Ltd Frequently Asked Questions
What is CARsgen Therapeutics Holdings Ltd(HKSE:02171)'s stock price today?
The current price of HKSE:02171 is HK$6.65. The 52 week high of HKSE:02171 is HK$9.78 and 52 week low is HK$2.48.
When is next earnings date of CARsgen Therapeutics Holdings Ltd(HKSE:02171)?
The next earnings date of CARsgen Therapeutics Holdings Ltd(HKSE:02171) is 2025-03-09 Est..
Does CARsgen Therapeutics Holdings Ltd(HKSE:02171) pay dividends? If so, how much?
CARsgen Therapeutics Holdings Ltd(HKSE:02171) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers